Unknown

Dataset Information

0

Brief Report: Real-World Performance and Interobserver Agreement of Urine Lipoarabinomannan in Diagnosing HIV-Associated Tuberculosis in an Emergency Center.


ABSTRACT: BACKGROUND:The urine lipoarabinomannan (LAM) lateral flow assay is a point-of-care test to diagnose HIV-associated tuberculosis (TB). We assessed the performance of urine LAM in HIV-positive patients presenting to the emergency center and evaluated the interobserver agreement between emergency center physicians and laboratory technologists. SETTING:A cross-sectional diagnostic study was performed at the emergency center of a district hospital in a high HIV-prevalence community in South Africa. METHODS:Consecutive HIV-positive adults presenting with ?1 WHO TB symptom were enrolled over a 16-month period. A urine LAM test was performed at point-of-care by an emergency physician and interpreted independently by 2 physicians. A second test was performed in the laboratory and interpreted independently by 2 laboratory technologists. The reference standard was a positive TB culture or Xpert MTB/RIF test on sputum or appropriate extrapulmonary samples. We compared diagnostic accuracy and reproducibility of urine LAM between point-of-care readers and laboratory readers. RESULTS:One thousand three hundred eighty-eight samples (median, 3 samples/participant) were sent for TB microbiology tests in 411 participants; 170 had confirmed TB (41.4%). Point-of-care and laboratory-performed urine LAM had similar sensitivity (41.8% vs 42.0%, P = 1.0) and specificity (90.5% vs 87.5%, P = 0.23). Moderate agreement was found between point-of-care and laboratory testing (? = 0.62), but there was strong agreement between point-of-care readers (? = 0.95) and between laboratory readers (? = 0.94). Positive percent agreement between point-of-care and laboratory readers was 68% and negative percent agreement 92%. CONCLUSION:There is no diagnostic accuracy advantage in laboratory-performed versus point-of-care-performed urine LAM tests in emergency care centers in high-burden settings.

SUBMITTER: Van Hoving DJ 

PROVIDER: S-EPMC6522362 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Brief Report: Real-World Performance and Interobserver Agreement of Urine Lipoarabinomannan in Diagnosing HIV-Associated Tuberculosis in an Emergency Center.

Van Hoving Daniël J DJ   Lahri Saʼad S   Lategan Hendrick J HJ   Nicol Mark P MP   Maartens Gary G   Meintjes Graeme G  

Journal of acquired immune deficiency syndromes (1999) 20190501 1


<h4>Background</h4>The urine lipoarabinomannan (LAM) lateral flow assay is a point-of-care test to diagnose HIV-associated tuberculosis (TB). We assessed the performance of urine LAM in HIV-positive patients presenting to the emergency center and evaluated the interobserver agreement between emergency center physicians and laboratory technologists.<h4>Setting</h4>A cross-sectional diagnostic study was performed at the emergency center of a district hospital in a high HIV-prevalence community in  ...[more]

Similar Datasets

| S-EPMC3215166 | biostudies-literature
| S-EPMC5745979 | biostudies-literature
| S-EPMC8099085 | biostudies-literature
| S-EPMC9307507 | biostudies-literature
| S-EPMC5393601 | biostudies-literature
| S-EPMC11293570 | biostudies-literature
| S-EPMC8013417 | biostudies-literature
| S-EPMC5529923 | biostudies-other
| S-EPMC4693620 | biostudies-other
| S-EPMC5021199 | biostudies-literature